BG61230B1 - Хелати и комплекси на антибиотици с бивалентни и/или тривалентни метали, метод за получаването им иизползването им за получаване на противоязвени средства - Google Patents

Хелати и комплекси на антибиотици с бивалентни и/или тривалентни метали, метод за получаването им иизползването им за получаване на противоязвени средства Download PDF

Info

Publication number
BG61230B1
BG61230B1 BG93995A BG9399591A BG61230B1 BG 61230 B1 BG61230 B1 BG 61230B1 BG 93995 A BG93995 A BG 93995A BG 9399591 A BG9399591 A BG 9399591A BG 61230 B1 BG61230 B1 BG 61230B1
Authority
BG
Bulgaria
Prior art keywords
azithromycin
bivalent
complexes
chelates
antibiotics
Prior art date
Application number
BG93995A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG93995A (bg
Inventor
Slobodan Djokic
Zlatko Vajtner
Hrvoje Krnjevic
Nevenka Lopotar
Lidija Kolacny-Babic
Original Assignee
Pliva Farmaceutska,Kemijska,Prehrambena Ikozmeticka Industrija Dionicko Drustvo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Farmaceutska,Kemijska,Prehrambena Ikozmeticka Industrija Dionicko Drustvo filed Critical Pliva Farmaceutska,Kemijska,Prehrambena Ikozmeticka Industrija Dionicko Drustvo
Publication of BG93995A publication Critical patent/BG93995A/bg
Publication of BG61230B1 publication Critical patent/BG61230B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BG93995A 1990-03-07 1991-03-06 Хелати и комплекси на антибиотици с бивалентни и/или тривалентни метали, метод за получаването им иизползването им за получаване на противоязвени средства BG61230B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU45590A YU45590A (sh) 1990-03-07 1990-03-07 Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje

Publications (2)

Publication Number Publication Date
BG93995A BG93995A (bg) 1993-12-24
BG61230B1 true BG61230B1 (bg) 1997-03-31

Family

ID=25550003

Family Applications (1)

Application Number Title Priority Date Filing Date
BG93995A BG61230B1 (bg) 1990-03-07 1991-03-06 Хелати и комплекси на антибиотици с бивалентни и/или тривалентни метали, метод за получаването им иизползването им за получаване на противоязвени средства

Country Status (20)

Country Link
US (1) US5498699A (cs)
EP (1) EP0445743B1 (cs)
JP (1) JP2731636B2 (cs)
CN (2) CN1041166C (cs)
AT (1) ATE143266T1 (cs)
BG (1) BG61230B1 (cs)
CA (1) CA2037663C (cs)
CZ (1) CZ280181B6 (cs)
DE (1) DE69122282T2 (cs)
DK (1) DK0445743T3 (cs)
ES (1) ES2094763T3 (cs)
GR (1) GR3021947T3 (cs)
HR (1) HRP940256B1 (cs)
HU (2) HU209455B (cs)
PL (1) PL166279B1 (cs)
RO (1) RO107660B1 (cs)
RU (2) RU2039060C1 (cs)
SI (1) SI9010455B (cs)
SK (1) SK279278B6 (cs)
YU (1) YU45590A (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
TW271400B (cs) * 1992-07-30 1996-03-01 Pfizer
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
AU4493796A (en) * 1995-01-26 1996-08-14 Nycomed Imaging As Bismuth compounds
US5900410A (en) * 1996-08-27 1999-05-04 Hartmann; John F. Monotherapy of peptic ulcers and gastritis
US6861411B1 (en) * 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
EP1671978A1 (en) 2001-05-22 2006-06-21 Pfizer Products Inc. New Cristal Form of Azithromycin
JP2005501862A (ja) * 2001-08-21 2005-01-20 ファイザー・プロダクツ・インク １回限りの投与量のアジスロマイシン
RU2283116C2 (ru) * 2002-05-27 2006-09-10 Курский государственный медицинский университет Способ увеличения выживаемости изолированного кожного лоскута "на ножке" у животных с пониженным антиоксидантным фоном
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
AU2005299294B2 (en) 2004-10-25 2012-06-07 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
US8440646B1 (en) 2006-10-11 2013-05-14 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of Bacillus anthracis infections
CN104892694A (zh) * 2015-05-24 2015-09-09 广西师范学院 蔗糖硫酸酯铜类化合物及其制作方法和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862225A (en) * 1961-08-18 1975-01-21 Pfizer D-ring substituted tetracyclines
US3622627A (en) * 1967-09-13 1971-11-23 Pfizer 4-dedimethylaminatetracycline and 5a, 6-anhydro derivatives thereof
HU167946B (cs) * 1973-04-16 1976-01-28
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
SG72632A1 (en) * 1985-04-18 2000-05-23 Procter & Gamble Treatment of non-ulcer dyspepsia with bismuth salts
ATE81010T1 (de) * 1985-06-13 1992-10-15 Barry James Marshall Zusammensetzungen zur behandlung von magendarmst¯rungen.
IT1200774B (it) * 1985-10-10 1989-01-27 Pierrel Spa Procedimento di sentisi dell'amikacina
YU44599B (en) * 1986-09-12 1990-10-31 Pliva Pharm & Chem Works Process for preparing complex of n-methyl-11-aza-10-deoxo-10-dihydroeritromicine a and 11-aza-10-deoxo-10-dihydroeritromicine a with metals
DE3860503D1 (de) * 1987-09-03 1990-10-04 Pliva Pharm & Chem Works 10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
US5196205A (en) * 1987-10-12 1993-03-23 Borody Thomas J Method for treatment of gastro intestinal disorders
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
DE391005T1 (de) * 1989-04-03 1991-04-11 Ranbaxy Laboratories, Ltd., New Delhi Verfahren zur herstellung von alpha-6-deoxytetracyclinen.
US5348946A (en) * 1991-02-28 1994-09-20 Biochem Immunosystems, Inc. Heteroanthracycline antitumor analogs
MA28714B1 (fr) * 2005-12-15 2007-07-02 Green Technlology Sarl Une arabinogalactane proteine ayant la propriete d'absorber les graisses et le procede d'obtention de cette arabinogalactane proteine

Also Published As

Publication number Publication date
CZ280181B6 (cs) 1995-11-15
HUT56849A (en) 1991-10-28
EP0445743A2 (en) 1991-09-11
HU209455B (en) 1994-06-28
JP2731636B2 (ja) 1998-03-25
JPH06184186A (ja) 1994-07-05
DE69122282D1 (de) 1996-10-31
GR3021947T3 (en) 1997-03-31
YU45590A (sh) 1992-07-20
HU211475A9 (en) 1995-11-28
CN1051560C (zh) 2000-04-19
EP0445743A3 (en) 1992-10-07
CS9100587A2 (en) 1991-10-15
RU2039060C1 (ru) 1995-07-09
CN1054534A (zh) 1991-09-18
CA2037663C (en) 1999-01-19
ATE143266T1 (de) 1996-10-15
EP0445743B1 (en) 1996-09-25
RU2039061C1 (ru) 1995-07-09
DE69122282T2 (de) 1997-04-24
CN1168891A (zh) 1997-12-31
SK279278B6 (sk) 1998-09-09
SI9010455B (sl) 2000-04-30
CN1041166C (zh) 1998-12-16
HRP940256A2 (en) 1997-06-30
US5498699A (en) 1996-03-12
RO107660B1 (ro) 1993-12-30
HU910740D0 (en) 1991-09-30
BG93995A (bg) 1993-12-24
DK0445743T3 (cs) 1997-02-17
CA2037663A1 (en) 1991-09-08
PL166279B1 (pl) 1995-04-28
SI9010455A (en) 1997-08-31
ES2094763T3 (es) 1997-02-01
HRP940256B1 (en) 1998-10-31

Similar Documents

Publication Publication Date Title
BG61230B1 (bg) Хелати и комплекси на антибиотици с бивалентни и/или тривалентни метали, метод за получаването им иизползването им за получаване на противоязвени средства
FI89052B (fi) Foerfarande foer framstaellning av ett kristallint hydrat av 7 -/(z)-2-(2-aminotiazol-4-yl)-4-karboxibut-2-enoylamino/-3-cefem-4-karboxylsyra
JPH09169757A (ja) Ｃｄｃｈの新規な結晶変態、その製造法及びこの変態を含む製薬学的調剤
EP0545194A1 (en) Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof
JPH09511991A (ja) ロバプラチナ三水和物
CA1303028C (en) Metal complexes of n-methyl-11-aza-10-deoxo-10- dihydroerythromycina or 11-aza-10-deoxo-10- dihydroerythromycin a, method for the manufacture thereof and their use in the manufacture of pharmaceuticals
BG64598B1 (bg) Платинов комплекс, метод за получаването му и терапевтичното му приложение
FI62311C (fi) Foerfarande foer framstaellning av kristallint natrium- och kaiumcefalexinmonohydrat
HU211431B (en) Process for preparation of humic acid-metal complexes
EP0923932B1 (en) Composition containing antitumor agent
KR860000450B1 (ko) α-6-데옥씨-5-하이드록씨 테트라 싸이클린과 소듐 테트라메타포스 페이트의 수용성 복합체의 제조방법
SU1701323A1 (ru) Способ получени противоопухолевого средства
CA2247329C (en) Composition containing antitumor agent
KR0144442B1 (ko) 수용성 비스무스 화합물 및 그의 제조 방법
KR101121942B1 (ko) 결정질 형태의 세팔로스포린
JPH08119862A (ja) ビスマス錯体およびそれを含有する抗菌剤
GB2200353A (en) Rifamycin derivative salts
KR850001133B1 (ko) 항펩신제의 제조방법
KR100226273B1 (ko) 신규 세팔로스포린계 수용성 유도체 및 그의 제조방법
JPH03271268A (ja) ２，６―ジメトキシヒドロキノン―３―メルカプトプロピオン酸および２，６―ジメトキシヒドロキノン―３―メルカプト酢酸およびその抗癌用途
CZ311091A3 (en) process for preparing bismuth oxide citrate
JPH0153668B2 (cs)
HU181455B (hu) Eljárás maltobionsav fémkomplexeinek előállítására
WO2000066174A2 (en) Compounds
PL116413B2 (en) Process for the preparation of novel water-soluble derivatives of staphylococcine